Alyeska Investment Group, L.P.

Position in ACHV — Achieve Life Sciences, Inc.

CIK 1453072 CHICAGO, IL

Position in ACHV

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$12,574,964

+$12,013,039 QoQ

Shares Held

1,925,722

+979.5% QoQ

Ownership

1.87%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#17

of 111 holders

Holding Since

Mar 2024

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Alyeska Investment Group, L.P. holds $989,063,778 across 83 Biotechnology names. ACHV ranks #19 (1.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	659,279	$123,469,771
2	IONS	Ionis Pharmaceuticals Inc	1,417,916	$112,426,559
3	PTGX	Protagonist Therapeutics, Inc	889,298	$109,010,148
4	XENE	Xenon Pharmaceuticals Inc.	697,692	$42,112,689
5	MRNA	Moderna, Inc.	560,819	$39,274,154
6	KYMR	Kymera Therapeutics, Inc.	276,455	$31,701,094
7	LBRX	Lb Pharmaceuticals Inc	863,947	$28,039,399
8	PRAX	Praxis Precision Medicines, Inc.	80,846	$27,066,432

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$12,574,964	1,925,722	+979.5%	Shares	Sole	2026-08-14
2025-09-30	$561,925	178,389	-94.9%	Shares	Sole	2025-11-17
2025-06-30	$7,919,792	3,504,333	+732.4%	Shares	Sole	2025-08-14
2025-03-31	$1,124,070	421,000	0.0%	Shares	Sole	2025-05-15
2024-12-31	$1,481,920	421,000	-10.6%	Shares	Sole	2025-02-14
2024-09-30	$2,232,540	471,000	0.0%	Shares	Sole	2024-11-14
2024-06-30	$2,213,700	471,000	0.0%	Shares	Sole	2024-08-14
2024-03-31	$2,143,050	471,000	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.